Håkan Axelson,Jennifer Hansson,David Lindgren,Lena Gustavsson,Elinn Johansson
申请号:
US15743352
公开号:
US20180200392A1
申请日:
2016.07.04
申请国别(地区):
US
年份:
2018
代理人:
摘要:
The invention provides methods and material for diagnosis and treatment of ccRCC. Thus, the invention relates to a method for diagnosis or treatment of clear cell renal cell carcinoma (ccRCC) in an individual in an individual in need thereof, wherein the method comprises use of an SLC6A3 ligand linked to a radioactive label, a cytotoxic moiety or an immunomodulatory moiety.